Skip to search formSkip to main contentSkip to account menu

Blast count procedure

Known as: BLAST, Blast Count, blast cells 
The determination of the number of blast cells present in a blood sample.
National Institutes of Health

Related topics

Related topics

6 relations
Blast CellCDISC SDTM Laboratory Test Terminology by CodeCDISC SDTM Laboratory Test Terminology by NameClinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Safety and efficacy of CYT387, a JAK-1/2 inhibitor, for the treatment of myelofibrosis.
6514 Background: CYT387 is a potent JAK-1/2 inhibitor. In an ongoing phase-1/2 multi-center study, 108 patients with… 
2011
2011
Isolated del(5q) in myeloid malignancies: Clinicopathologic and molecular features in 143 consecutive patients
World Health Organization (WHO) criteria were used to identify 143 consecutive patients (median age 73 years; 90 females) with… 
Review
2003
Review
2003
Burkitt's leukemia with precursor B-cell immunophenotype and atypical morphology (atypical Burkitt's leukemia/lymphoma): case report and review of literature.
2001
2001
Clinical Outcome of Patients with Childhood Acute Lymphoblastic Leukaemia and an Initial Leukaemic Blood Blast Count of Less than 1000 per Microliter
Background: Patients and methods: Results: Conclusion: Hintergrund: Patienten und Methoden: Ergebnisse: Schlussfolgerung: 
2001
2001
Childhood Acute Lymphoblastic Leukemia: Prognostic Value of Initial Peripheral Blast Count in Good Responders to Prednisone
Purpose To assess the value of initial peripheral blast count in patients with acute lymphoblastic leukemia (ALL) and prednisone… 
Highly Cited
2000
Highly Cited
2000
Risk factors for severe neuropsychiatric toxicity in patients receiving interferon alfa-2b and low-dose cytarabine for chronic myelogenous leukemia: analysis of Cancer and Leukemia Group B 9013.
PURPOSE Recombinant interferon alfa-2b (rIFNalpha2b) is a standard therapy for chronic myelogenous leukemia (CML). Severe… 
1996
1996
Peripheral blast counts at diagnosis of late isolated bone marrow relapse of childhood acute lymphoblastic leukemia predict response to salvage chemotherapy and outcome. Berlin-Frankfurt-Münster…
PURPOSE In newly diagnosed childhood acute lymphoblastic leukemia (ALL), a high tumor burden indicates a poor prognosis, while no… 
1993
1993
Hypermethylation of the calcitonin gene in the myelodysplastic syndromes.
It is well documented that the calcitonin gene area in the short arm of chromosome 11 is hypermethylated in most acute leukemias… 
1988
1988
Short-term therapy for acute myelogenous leukemia.
Since 1978, 187 patients (age range, 15 to 59, median 44 years) have received short-term chemotherapy as part of three sequential… 
1978
1978
Rapid Cytoreduction in Acute Leukemia
A patient with acute myelogenous leukemia and symptoms of cerebral leukostasis failed to respond to initial chemotherapy… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)